Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Gerber

Showing results (51-60 of 288) with videos related to

Pageof 29
Sort By:
JAMA Oncology|November 24, 2017
Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results ProgramCaitlin C Murphy, David E Gerber, Sandi L Pruitt
Cancer Chemotherapy and Pharmacology|September 15, 2006
Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphomaDavid E Gerber, Stuart A Grossman, Tracy Batchelor, et al.
Clinical Lung Cancer|January 15, 2020
Timing, Sites, and Correlates of Lung Cancer RecurrenceChelsea M Karacz, Jingsheng Yan, Hong Zhu, et al.
Cancer Biology & Therapy|August 16, 2021
Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assayDavid Hsiehchen, Magdalena Espinoza, David E Gerber, et al.
Cancer Research|July 12, 2021
Contemporary Lung Cancer Screening and the Promise of Blood-Based BiomarkersMitchell S von Itzstein, David E Gerber, John D Minna
JTO Clinical and Research Reports|September 30, 2021
Thirteen-Year Survival in a Patient With Diffuse Bilateral Lepidic-Predominant Adenocarcinoma: A Case Report of Lung Transplantation and Local SalvageElizabeth R Zhang-Velten, David E Gerber, Kenneth D Westover
Translational Lung Cancer Research|August 25, 2021
Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancerSawsan Rashdan, Puneeth Iyengar, John D Minna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2009
Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?Jeffrey T Yorio, Yang Xie, Jingsheng Yan, et al.
Ebiomedicine|September 25, 2020
Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients?Mitchell S von Itzstein, David E Gerber, John D Minna
Journal of Medical Case Reports|July 24, 2022
Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case reportAmrit S Gonugunta, Mitchell S von Itzstein, David E Gerber
Pageof 29

Showing results (51-60 of 288) with videos related to

Sort By:
Pageof 29
JAMA Oncology|November 24, 2017
Prevalence of Prior Cancer Among Persons Newly Diagnosed With Cancer: An Initial Report From the Surveillance, Epidemiology, and End Results ProgramCaitlin C Murphy, David E Gerber, Sandi L Pruitt
Cancer Chemotherapy and Pharmacology|September 15, 2006
Calculated versus measured creatinine clearance for dosing methotrexate in the treatment of primary central nervous system lymphomaDavid E Gerber, Stuart A Grossman, Tracy Batchelor, et al.
Clinical Lung Cancer|January 15, 2020
Timing, Sites, and Correlates of Lung Cancer RecurrenceChelsea M Karacz, Jingsheng Yan, Hong Zhu, et al.
Cancer Biology & Therapy|August 16, 2021
Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assayDavid Hsiehchen, Magdalena Espinoza, David E Gerber, et al.
Cancer Research|July 12, 2021
Contemporary Lung Cancer Screening and the Promise of Blood-Based BiomarkersMitchell S von Itzstein, David E Gerber, John D Minna
JTO Clinical and Research Reports|September 30, 2021
Thirteen-Year Survival in a Patient With Diffuse Bilateral Lepidic-Predominant Adenocarcinoma: A Case Report of Lung Transplantation and Local SalvageElizabeth R Zhang-Velten, David E Gerber, Kenneth D Westover
Translational Lung Cancer Research|August 25, 2021
Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancerSawsan Rashdan, Puneeth Iyengar, John D Minna, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2009
Lung cancer diagnostic and treatment intervals in the United States: a health care disparity?Jeffrey T Yorio, Yang Xie, Jingsheng Yan, et al.
Ebiomedicine|September 25, 2020
Do mRNA profiles of lung adenocarcinomas provide information that will help individual patients?Mitchell S von Itzstein, David E Gerber, John D Minna
Journal of Medical Case Reports|July 24, 2022
Pseudoprogression in advanced non-small cell lung cancer treated with combination chemoimmunotherapy: a case reportAmrit S Gonugunta, Mitchell S von Itzstein, David E Gerber
Pageof 29